Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer

Cancer Research

Volumn 57, Issue 1, 1997, Pages 136-140

  O'Brien, Tim ^a,b,c   Cranston, David ^c   Fuggle, Susan ^b   Bicknell, Roy ^a   Harris, Adrian L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA;

ANGIOGENESIS; ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CONTROLLED STUDY; DETRUSOR MUSCLE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PRIORITY JOURNAL;

FIBROBLAST GROWTH FACTOR 2; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; URINARY BLADDER NEOPLASMS;

EID: 0031031896     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer, Inst., 82: 4-6, 1990.
2. Dickinson, A. J., Fox, S. B., Persad, R., Hollyer, J., Sibley, G., and Harris, A. L. Quanlitation of angiogenesis is an independent predictor of prognosis in invasive bladder cancer. Br. J. Urol., 74: 762-766, 1994.
3. Jaeger, T., Weidner, N., Chew, K., Moore, D., Kerschmann, R., Waldmann, F., and Carroll, P. Tumour angiogenesis correlates with lymph node metastases in invasive bladder cancer. J. Urol., 154: 69-71, 1995.
4. Horak, E. R., Leek, R., Klenk, N., Le Jeune, S., Smith, K., Stuart, N., Greenall, M., Stepniewska, K., and Harris, A. L. Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer. Lancet, 340: 1120-1124, 1992.
5. Weidner, N., Semple, J. P., and Welch, W. R. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
6. Srivastava, A., Laidler, P., Davies, R., Morgan, K., and Hughes, L. E. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4 mm thick) skin melanoma. Am. J. Pathol., 133: 419-423, 1988.
7. Weidner, N., Carroll, P., Flax, J., Blumenfeld, D., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostatic cancer. Am. J. Pathol., 143: 401-409, 1993.
8. O prostatic adenocarcinoma. Anticancer Res., 14: 709-714, 1994.
9. Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., Asano, K., Tokuda, T., Aizawa, S., and Ushigome, S. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J. Pathol., 168: 257-262, 1992.
10. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
11. Bicknell, R., and Harris, A. L. Novel growth regulatory factors and tumour angiogenesis. Eur. J. Cancer, 27: 781-785, 1991.
12. Rifkin, D., and Moscatelli, D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol., 109: 1-6, 1989.
13. Hughes, S., and Hall, P. The fibroblast growth factor and receptor multigene families. J. Pathol., 170: 219-221, 1993.
14. Saksela, O., Moscatelli, D., Sommer, A., and Rifkin, D. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol., 107: 743-751, 1988.
15. Baird, A., and Ling, N. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem. Biophys. Res. Commun., 142: 428-435, 1987.
16. Bashkin, P., Doctrow, S., Klagsbrun, M., Svahn, C. M., Folkman, J., and Vlodavsky, I. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry, 28: 1737-1743, 1989.
17. Kandel, J., Bossy, W. E., Radvanyi, F., Klagsbrun, M., Folkman, J., and Hanahan, D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell. 66: 1095-1104, 1991.
18. Jackson, A., Friedman, S., Zhan, X., Engleka, K., Forough, R., and Maciag, T. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. USA. 89: 10691-10695, 1992.
19. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst., 86: 356-361, 1994.
20. Nanus, D., Schmitz-Drager, B., Motzer, R., Lee, A., Vlamis, V., Cordon-Cardo, C., Albino, A. P., and Reuter, V. E. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J. Natl. Cancer Inst., 85: 1597-1599, 1993.
21. Hori, A., Sasada, R., Matsutani, E., Naito, K., Sakura, Y., Fujita, T., and Kozai, Y. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res., 51: 6180-6184, 1991.
22. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
23. Chopin, D. K., Caruelle, J. P., Colombel, M., Palcy, S., Ravery, V., Caruelle, D., Abbou, C. C., and Barritault, D. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J. Urol., 150: 1126-1130, 1993.
24. Nguyen, M., Watanabe, H., Budson, A., Richie, J., and Folkman, J. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst., 85: 241-242, 1993.
25. O'Brien, T., Smith, K., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. Urinary basic fibroblast growth factor is elevated in patients with bladder cancer and benign prostatic hypertrophy. Br. J. Urol., 76: 311-314, 1995.
26. Ravery, V., Jouanneau, J., Gil, D. S., Abbou, C. C., Caruelle, J. P., Barritault, D., and Chopin, D. K. Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma. Urol. Res., 20: 211-214, 1992.
27. Chomczynski, P., and Saachi, N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
28. 1. J. Biol. Chem., 267: 21617-21622, 1992.
29. Smith, K., Houlbrook, S., Greenhall, M., Carmichael, J., and Harris, A. Topoisomerase II alpha coamplification with erb-2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity. Oncogene, 8: 933-938, 1993.
30. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Anal. Biochem., 72: 248-254, 1976.
31. Matsuzaki, K., Yoshitake, Y., Matuo, Y., Sasaki, H., and Nishikawa, K. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumour angiogenesis. Proc. Natl. Acad. Sci. USA, 86: 9911-9915, 1989.
32. Reilly, T. M., Taylor, D. S., Herblin, W. F., Thoolen, M. J., Chiu, A. T., Watson, D. W., and Timmermans, P. B. Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochem. Biophys. Res. Commun., 164: 736-743, 1989.
33. Luqmani, Y. A., Graham, M., and Coombes, R. C. Expression of basic fibroblast growth factor. FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br. J. Cancer, 66: 273-280, 1992.
34. Anandappa, S. Y., Winstanley, J. H., Leinster, S., Green, B., Rudland, P. S., and Barraclough, R. Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br. J. Cancer, 69: 772-776, 1994.
35. Takahashi, J., Mori, H., Fukomoto, M., Igarashi, K., Jaye, M., Oda, Y., Kikuchi, H., and Hatanaka, M. Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumour tissues. Proc. Natl. Acad. Sci. USA, 87: 5710-5714, 1990.
36. Eguchi, J., Nomata, K., Kanda, S., Igawa, T., Taide, M., Koga, S., Matsuya, F., Kanetake, M., and Saito, Y. Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma. Biochem. Biophys. Res. Commun., 183: 937-944, 1992.
37. Cordon-Cardo, C., Vlodavsky, I., Haimovitz, F. A., Hicklin, D., and Fuks, Z. Expression of basic fibroblast growth factor in normal human tissues. Lab. Invest., 63: 832-840, 1990.
38. Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai, M. R., Sasse, J., and Klagsbrun, M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA, 84: 2292-2296, 1987.
39. Folkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D., and Vlodavsky, I. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am. J. Pathol., 130: 393-400, 1988.